Tanja Dowe

Tanja Dowe has a diverse work experience in various leadership and board positions. Tanja is currently the Managing Director at Angelini Ventures since June 2023. Prior to that, they served as a Board Member at Reaktor and VivoSense, Inc. starting in 2022. Tanja has also held board positions at Novadiscovery, Oncomfort, Voluntis, Kaiku Health, and GenePOC. In addition, they had significant roles at Debiopharm International SA, where they were the CEO of Debiopharm Innovation Fund S.A. and Head of Debiopharm Innovation Fund from 2016 to 2023. Tanja was also a Member of the Steering Board in the Living Factories program from 2015 to 2016. Overall, Tanja Dowe has a strong background in leadership, board governance, and strategic advisory roles in the digital health and biotechnology sectors.

Tanja Dowe obtained their MSc Tech. degree in Applied microbiology from Teknillinen korkeakoulu-Tekniska högskolan between 1995 and 2000. Their minors during this period were biochemistry and bioprocess engineering.